Yes, cancer patients can get dental implants, but the timing, type of cancer treatment, and condition of the jawbone all shape whether it’s safe and how well the implants will hold. For many cancer survivors, implants are not only possible but are a key part of oral rehabilitation, especially after head and neck cancers that involve jaw surgery. The overall implant survival rate in head and neck cancer patients is around 88%, which is lower than the general population but still high enough to make implants a realistic option for most people who’ve completed treatment.
When Implants Are Safe After Treatment
The most important rule is straightforward: chemotherapy and radiation therapy need to be finished before implant surgery. During and shortly after chemotherapy, your body’s ability to heal and fight infection drops sharply. White blood cell counts typically bottom out around 10 days after a chemotherapy cycle, and platelet counts follow a few days later. Both need to recover before any surgical procedure.
Specifically, implant surgery is postponed if your platelet count is below 100,000 per cubic millimeter or your white blood cell count is below 1,000 per cubic millimeter. Your oncology and dental teams will check these numbers with blood work before clearing you for surgery. Most clinicians recommend waiting several months after the last round of chemotherapy to ensure stable blood counts and adequate healing capacity.
How Radiation Changes the Picture
Radiation to the head and neck is the single biggest factor in determining implant success. Radiation damages blood vessels in the jawbone, reducing blood flow and slowing the bone’s ability to heal around a new implant. But the risk isn’t uniform. It depends heavily on how much radiation the specific implant site received.
Research published in Head & Neck identified a critical threshold: when the average radiation dose at the implant site was below 38 Gy (a unit measuring radiation absorbed by tissue), no implants failed. Above 38 Gy, the three-year survival rate dropped to just 44.2%. That’s a dramatic difference, and it means your radiation oncologist’s treatment records are essential for planning implant placement. If the area where you need an implant received a lower dose, the odds are strongly in your favor.
One serious but uncommon complication of implant surgery in irradiated bone is osteoradionecrosis, where the bone fails to heal and begins to break down. A meta-analysis of irradiated head and neck cancer patients found this occurred at a rate of about 1.8%. It’s rare, but it’s the reason dental teams approach irradiated jawbone with extra caution.
Hyperbaric Oxygen Therapy Before Implants
For patients whose jawbone received higher radiation doses, some treatment centers offer hyperbaric oxygen therapy before implant placement. You sit in a pressurized chamber breathing pure oxygen, which stimulates blood vessel growth and improves oxygen delivery to damaged bone tissue. A meta-analysis found that preventive hyperbaric oxygen therapy reduced the risk of implant failure in irradiated patients, likely because the improved blood supply helps the bone integrate with the implant more effectively. Not every patient needs this step, but it’s a tool that can tip the odds when the jawbone has been significantly affected by radiation.
Bone-Modifying Medications and Jaw Risk
Many cancer patients take medications that strengthen bones or slow bone loss from metastatic disease. These drugs, commonly given by IV infusion for cancers that have spread to bone, create a specific risk for dental implant surgery: medication-related osteonecrosis of the jaw (MRONJ). This is a condition where the jawbone becomes exposed and fails to heal.
IV bone-modifying agents used at the higher doses typical in cancer treatment carry a meaningfully higher MRONJ risk than the lower-dose versions prescribed for osteoporosis. In one four-year study of patients receiving high-dose treatment, the overall incidence of jaw osteonecrosis was about 5 per 100 person-years. Dental implants were among the factors that could trigger the condition, along with tooth extractions and periodontal disease. For this reason, implant placement while actively receiving IV bone-modifying therapy is generally considered a contraindication, particularly when these drugs are combined with corticosteroids or immunosuppressants.
If you’ve been on these medications, your dental team will want to know the specific drug, dose, and how long you took it. The risk profile differs substantially between someone who had a few infusions and someone who has been on continuous therapy for years.
Implants in Reconstructed Jawbone
Patients who’ve had part of their jaw removed due to cancer often undergo reconstruction with bone grafts, either taken from another part of their body (like the leg or hip) or using other grafting techniques. Implants can be placed in this reconstructed bone, but the success rate is lower than in natural bone.
In a study with a mean follow-up of nearly three years, implants placed in grafted bone had a 76% survival rate compared to 91% in the patient’s original bone. Whether the graft was a free vascularized flap or a nonvascularized graft didn’t make much difference, with both types showing about 75-76% survival. The lower success rate likely comes from differences in bone density and soft tissue quality compared to native jaw.
Another common issue in grafted areas is mucosal overgrowth, where the gum tissue grows excessively around the implant. This occurred in 86% of overgrowth cases in grafted sites versus nongrafted areas. It’s manageable but may require additional minor procedures. If your jaw has been reconstructed, expect that the implant process will involve closer monitoring and potentially more follow-up visits than it would for someone with intact jawbone.
Dental Work Before Cancer Treatment
If you haven’t started cancer treatment yet, the dental work you do now can significantly affect your options later. Standard protocols call for a thorough dental evaluation before chemotherapy or radiation begins. This includes a panoramic X-ray to get a full picture of your oral health, along with closer images of any teeth that look questionable.
Teeth that can’t be saved, have deep periodontal pockets (6 millimeters or more), significant mobility, or are partially impacted should be extracted before treatment starts. The goal is to eliminate any sources of infection or irritation that could become serious problems once your immune system is suppressed or your jawbone has been irradiated. Removing problem teeth beforehand also simplifies future implant planning, because extractions in irradiated bone carry their own risks.
This pre-treatment dental visit isn’t just about damage control. It’s also when your dental and oncology teams can start mapping out a long-term rehabilitation plan, identifying where implants might eventually go and making sure the cancer treatment plan accounts for that whenever possible.
What Determines Your Individual Risk
No single factor determines whether implants will work for you. The decision is based on a combination of variables that your dental and oncology teams weigh together:
- Radiation dose at the implant site: Below 38 Gy is favorable; above that threshold, risk climbs steeply.
- Current medications: Active IV bone-modifying therapy is the most significant medication concern.
- Bone quality: Native bone performs better than grafted bone, and non-irradiated bone performs better than irradiated bone.
- Blood counts: Adequate platelet and white blood cell levels are required before surgery.
- Time since treatment: More time between the end of cancer therapy and implant placement generally means better healing conditions.
The best outcomes happen when implant placement is treated as a coordinated effort between your oncologist, oral surgeon, and prosthodontist rather than a standalone dental procedure. With the right planning and timing, the majority of cancer survivors who pursue dental implants end up with functional, lasting results.